Sporadic Creutzfeldt-Jakob Disease in a Young Girl With Unusually Long Survival.


Journal

Journal of neuropathology and experimental neurology
ISSN: 1554-6578
Titre abrégé: J Neuropathol Exp Neurol
Pays: England
ID NLM: 2985192R

Informations de publication

Date de publication:
01 04 2019
Historique:
pubmed: 12 3 2019
medline: 13 6 2020
entrez: 12 3 2019
Statut: ppublish

Résumé

Creutzfeldt-Jakob disease (CJD) is a rapidly progressive, fatal degenerative encephalopathy caused by a pathologically altered form of the prion protein (PrP). CJD is rare, with 1 and 2 cases per million per year reported in the general population, mostly in individuals over 50 years of age. It is almost unknown in the pediatric population. Sporadic CJD with unusually long survival (sCJD-LS), an unusual clinicopathological variant of CJD, has been described mostly in Japanese patients. We present here the first case report of pediatric CJD-LS occurring sporadically in a teenage girl of European descent, with initially rapid neurocognitive decline followed by a prolonged (∼10 years) clinical course. Neuropathological findings at autopsy included generalized cerebral and cerebellar atrophy with relative sparing of the hippocampi, cerebral and cerebellar white and gray matter involvement, minimal spongiform change, PrP deposits in the neocortex, striatum and cerebellum by immunohistochemistry, and protease-resistant PrP by Western immunoblot. With its longer disease duration and atypical manifestations of white matter loss, CJD-LS can be clinically mistaken for other neurodegenerative diseases, or in the pediatric setting for metabolic/genetic conditions. This case clearly demonstrates that with rapid-onset encephalopathy, prion disease should be carefully considered, even in younger patients with slower disease progression.

Identifiants

pubmed: 30856268
pii: 5374644
doi: 10.1093/jnen/nlz013
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-378

Informations de copyright

© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Auteurs

Colleen E D'Arcy (CE)

Division of Pathology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Ari Bitnun (A)

Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.

Michael B Coulthart (MB)

Canadian Creutzfeldt-Jakob Disease Surveillance System, Public Health Agency of Canada, Ottawa, Canada.

Rolande D'Amour (R)

Canadian Creutzfeldt-Jakob Disease Surveillance System, Public Health Agency of Canada, Ottawa, Canada.

Jeremy Friedman (J)

Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

J David Knox (JD)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Adam Rapoport (A)

Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.

Snead Carter (S)

Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.

Elysa Widjaja (E)

Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada.

Lili-Naz Hazrati (LN)

Division of Pathology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Gerard H Jansen (GH)

Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH